复杂疾病组合的遗传结构解析框架:在心血管医学中的应用
A framework to decipher the genetic architecture of combinations of complex diseases: applications in cardiovascular medicine
摘要:
全基因组关联研究(GWAS)已被证明在揭示复杂疾病的遗传基础方面非常有用。目前,大多数GWAS是针对对照的特定单一疾病诊断的研究。然而,在实践中,一个人往往受到一个以上的条件/障碍。例如,患有冠状动脉疾病(CAD)的患者通常与糖尿病(DM)共病。沿着类似的路线,研究患有一种疾病但没有合并症的患者通常具有临床意义。例如,肥胖DM可能具有与非肥胖DM不同的病理生理学。在这里,我们开发了一个统计框架来揭示共病疾病(或无共病疾病)的易感性变异,仅使用GWAS汇总统计。从本质上讲,我们模拟了一个病例对照GWAS,其中病例受合并症或疾病的影响,而没有相关的合并症(在任何一种情况下,我们都可以认为这些病例受特定疾病亚型的影响,其特征是存在或不存在合并症)。我们扩展了我们的方法,以处理具有临床意义的类别(例如脂质)的连续性状。此外,我们说明了如何分析框架可以扩展到两个以上的特质。我们验证了我们的方法的可行性和有效性,将其应用于模拟场景和四个心脏代谢(CM)性状。我们还分析了CM疾病亚型中涉及的基因、通路、细胞类型/组织。LD评分回归分析显示,某些亚型可能确实具有低遗传相关性的生物学差异。进一步的孟德尔随机化分析发现不同亚型对相关并发症的因果影响不同。我们相信这些发现具有科学和临床价值,并且所提出的方法可能为分析GWAS数据开辟新的途径。
英文摘要:
Genome-wide association studies(GWAS) have proven to be highly useful in revealing the genetic basis of complex diseases. At present, most GWAS are studies of a particular single disease diagnosis against controls. However, in practice, an individual is often affected by more than one condition/disorder. For example, patients with coronary artery disease(CAD) are often comorbid with diabetes mellitus(DM). Along a similar line, it is often clinically meaningful to study patients with one disease but without a comorbidity. For example, obese DM may have different pathophysiology from non-obese DM. Here we developed a statistical framework to uncover susceptibility variants for comorbid disorders (or a disorder without comorbidity), using GWAS summary statistics only. In essence, we mimicked a case-control GWAS in which the cases are affected with comorbidities or a disease without a relevant comorbid condition (in either case, we may consider the cases as those affected by a specific subtype of disease, as characterized by the presence or absence of comorbid conditions). We extended our methodology to deal with continuous traits with clinically meaningful categories (e.g. lipids). In addition, we illustrated how the analytic framework may be extended to more than two traits. We verified the feasibility and validity of our method by applying it to simulated scenarios and four cardiometabolic (CM) traits. We also analyzed the genes, pathways, cell-types/tissues involved in CM disease subtypes. LD-score regression analysis revealed some subtypes may indeed be biologically distinct with low genetic correlations. Further Mendelian randomization analysis found differential causal effects of different subtypes to relevant complications. We believe the findings are of both scientific and clinical value, and the proposed method may open a new avenue to analyzing GWAS data.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。